In vivo, CSF1KD mice exhibited reduced osteolytic activity, likely induced by CSF-1 produced by tumor cells, as well as decreased CSCs and osteoclastogenesis, thereby blunting tumor progression [154]. The gene discussed is CSF1; the disease is neoplasm.